Aryl Hydrocarbon Receptor Activation Down-Regulates IL-7 and Reduces Inflammation in a Mouse Model of DSS-Induced Colitis

Digestive Diseases and Sciences

Volumn 60, Issue 7, 2015, Pages 1958-1966

  Ji, Tao ^a   Xu, Chao ^a   Sun, Lihua ^a   Yu, Min ^a   Peng, Ke ^a   Qiu, Yuan ^a   Xiao, Weidong ^a   Yang, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aryl hydrocarbon receptor; Ficz; Gut immunity; IBD; IL 7

Indexed keywords

6 FORMYLINDOLO (3,2 B) CARBAZOLE; AROMATIC HYDROCARBON RECEPTOR; CARBAZOLE DERIVATIVE; DEXTRAN SULFATE; INTERLEUKIN 7; MESSENGER RNA; UNCLASSIFIED DRUG; 6-FORMYLINDOLO(3,2-B)CARBAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CD8+ T LYMPHOCYTE; CELL ISOLATION; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENTERITIS; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; CD4+ T LYMPHOCYTE; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; PHYSIOLOGY;

ANIMALS; CARBAZOLES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; COLITIS; DEXTRAN SULFATE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-7; MICE; RECEPTORS, ARYL HYDROCARBON;

EID: 84930818280     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3632-x     Document Type: Article

References (44)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.
2. De Robertis M, Massi E, Poeta ML, et al. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog. 2011;10:9.
3. Kanneganti M, Mino-Kenudson M, Mizoguchi E. Animal models of colitis-associated carcinogenesis. J Biomed Biotechnol. 2011;2011:342637.
4. Melgar S, Karlsson L, Rehnstrom E, et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol. 2008;8:836–844.
5. Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol. 2008;21:102–116.
6. Kewley RJ, Whitelaw ML, Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol. 2004;36:189–204.
7. Kerkvliet NI, Baecher-Steppan L, Shepherd DM, et al. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol. 1996;157:2310–2319.
8. Kerkvliet NI. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect. 1995;103:47–53.
9. Monteleone I, Rizzo A, Sarra M, et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology. 2011;141:237–248.
10. Li Y, Innocentin S, Withers DR, et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell. 2011;147:629–640.
11. Watanabe M, Uen Y, Yajima T, et al. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest. 1995;95:2945–2953.
12. Hara T, Shitara S, Imai K, et al. Identification of IL-7-producing cells in primary and secondary lymphoid organs using IL-7-GFP knock-in mice. J Immunol. 2012;189:1577–1584.
13. Porter BO, Malek TR. Thymic and intestinal intraepithelial T lymphocyte development are each regulated by the gammac-dependent cytokines IL-2, IL-7, and IL-15. Semin Immunol. 2000;12:465–474.
14. Carvalho TL, Mota-Santos T, Cumano A, Demengeot J, Vieira P. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)-mice. J Exp Med. 2001;194:1141–1150.
15. Yamazaki M, Yajima T, Tanabe M, et al. Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. J Immunol. 2003;171:1556–1563.
16. Watanabe M, Yamazaki M, Okamoto R, et al. Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathway. Curr Drug Targets Inflamm Allergy. 2003;2:119–123.
17. Dooms Hans. Interleukin-7: Fuel for the autoimmune attack. J Autoimmun. 2013;45:40–48.
18. Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol. 2006;24:657–679.
19. Bradley LM, Haynes L, Swain SL. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 2005;26:172–176.
20. Yang H, Madison B, Gumucio DL, et al. Specific overexpression of IL-7 in the intestinal mucosa: the role in intestinal intraepithelial lymphocyte development. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1421–G1430.
21. Fry TJ, Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T-cell maintenance. J Immunol. 2005;174:6571–6576.
22. Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol. 2011;11:445–456.
23. Poussier P, Ning T, Banerjee D, et al. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J Exp Med. 2002;195:1491–1497.
24. Montufar-Solis D, Garza T, Klein JR. T-cell activation in the intestinal mucosa. Immunol Rev. 2007;215:189–201.
25. Mosley RL, Klein JR. A rapid method for isolating murine intestine intraepithelial lymphocytes with high yield and purity. J Immunol Methods. 1992;156:19–26.
26. Zhang L, Ma J, Takeuchi M, et al. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Investig Ophthalmol Visual Sci. 2010;51:2109–2117.
27. Benson JM, Shepherd DM. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn’s disease. Toxicol Sci. 2011;120:68–78.
28. Schulz VJ, Smit JJ, Willemsen KJ, et al. Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. Toxicol Sci. 2011;123:491–500.
29. Nohara K, Pan X, Tsukumo S, et al. Constitutively active aryl hydrocarbon receptor expressed specifically in T-lineage cells causes thymus involution and suppresses the immunization-induced increase in splenocytes. J Immunol. 2005;174:2770–2777.
30. von Freeden-Jeffry U, Davidson N, Wiler R, Fort M, Burdach S, Murray R. IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. J Immunol. 1998;161:5673–5680.
31. Shinohara T, Nemoto Y, Kanai T, et al. Upregulated IL-7 receptor alpha expression on colitogenic memory CD4þ T cells may participate in the development and persistence of chronic colitis. J Immunol. 2011;186:2623–2632.
32. Okada E, Yamazaki M, Tanabe M, et al. IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice. Am J Physiol Gastrointest Liver Physiol. 2005;288:G745–G754.
33. Watanabe M, Yamazaki M, Okamoto R, et al. Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathway. Curr Drug Targets Inflamm Allergy. 2003;2:119–123.
34. Yang H, Madison B, Gumucio DL, et al. Specific overexpression of IL-7 in the intestinal mucosa: the role in intestinal intraepithelial lymphocyte development. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1421–G1430.
35. Vidali F, Di Sabatino A, Broglia F, et al. Increased CD8+ intraepithelial lymphocyte infiltration and reduced surface area to volume ratio in the duodenum of patients with ulcerative colitis. Scand J Gastroenterol. 2010;45:684–689.
36. Yang H, Gumucio DL, Teitelbaum DH. Intestinal specific overexpression of interleukin-7 attenuates the alternation of intestinal intraepithelial lymphocytes after total parenteral nutrition administration. Ann Surg. 2008;248:849–856.
37. Cheroutre H. In IBD eight can come before four. Gastroenterology. 2006;131:667–670.
38. Tajima M, et al. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J Exp Med. 2008;205:1019–1027.
39. Nancey S, et al. CD8+ cytotoxic T cells induce relapsing colitis in normal mice. Gastroenterology. 2006;131:485–496.
40. Jabri B, et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology. 2000;118:867–879.
41. Komano H, et al. Homeostatic regulation of intestinal epithelia by intraepithelial γδ T cells. Proc Natl Acad Sci USA. 1995;92:6147–6151.
42. Guy-Grand D, DiSanto JP, Henchoz P, et al. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-γ, TNF) in the induction of epithelial cell death and renewal. Eur J Immunol. 1998;28:730–744.
43. + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci USA. 1996;93:11774–11779.
44. Montufar-Solis D, Garza T, Klein JR. T-cell activation in the intestinal mucosa. Immunol Rev. 2007;215:189–201.